Sarepta Wins Exon 51 Composition Patent Rights Over BioMarin

Patent Trial and Appeal Board rules against BioMarin in proceeding to determine who has rights to a composition of matter patent for eteplirsen; last year the board ruled in BioMarin's favor on method of use patent.